Waverx, Inc.

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 25.0

Forward Citations = 19

Loading Chart...

6 inventors (with patents filed for the assignee):

Peter A Hoenig (3 out of 3 patents)

Stuart B Trembly (3 out of 18 patents)

Michael S Brogan (1 out of 3 patents)

4. Laura E Edsberg (1 out of 3 patents)

5. Douglas P Kalinowski (1 out of 3 patents)

6. Laura L Deming (1 out of 3 patents)

4 patents: Sort by Forward Citations

1. 8396564 - Apparatus and method for the treatment of infectious disease in keratinized tissue (2013-03-12),

2. 8295925 - Methods and devices for treating neuropathy and loss of protective sensation (2012-10-23),

3. 7744592 - Apparatus and method for the treatment of infectious disease in keratinized tissue (2010-06-29),

4. 7292893 - Apparatus and method for the treatment of infectious disease in keratinized tissue (2007-11-06),

Company Overview

Waverx, Inc. is a leading biotechnology company specializing in the development of innovative therapies for rare and complex diseases. With a focus on personalized medicine, Waverx is committed to advancing science and improving patient outcomes. Their team of experts includes researchers, scientists, and medical professionals dedicated to revolutionizing healthcare through groundbreaking treatments and technologies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

4 Patents

#202 in Waltham, MA

#3,316 in Massachusetts

#60,701 in US

Waltham, MA, United States of America

Waverx, Inc.

Forward Citations = 19

6 inventors:

Peter A Hoenig (3 out of 3 patents)

Stuart B Trembly (3 out of 18 patents)

Michael S Brogan (1 out of 3 patents)

4. Laura E Edsberg (1 out of 3 patents)

5. Douglas P Kalinowski (1 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Waverx, Inc.. Retrieved from https://idiyas.com/company/waverx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]